Is a complete XTLB research report available?

No complete published report is available for XTL Biopharmaceuticals Ltd. (XTLB) on this page. Market-directory data, when present, is not a substitute for a validated stock analysis.

XTL Biopharmaceuticals Ltd. (XTLB)

NASDAQ: XTLB · USD

$1.73

+0.02 (+1.5%)· Recorded snapshot

Market cap	5.9M
Net income (ttm)	-7M
EPS (ttm)	-$3.16
Shares out	983M
Volume	5,495.402
Beta	0.42

Market data

Price

Recent price action with selectable time range.

Financial snapshot

Net income (ttm): -7M
EPS (ttm): -$3.16
Market cap: 5.9M

Ticker	Name	Market cap	P/E	P/S	ROIC	5Y rev CAGR	1Y total return	Rating
EXAS	Exact Sciences Corp	—	—	—	—	—	—	Mantener

Metric	Value
Amount currency	USD
CIK code	0001023549
Company name	XTL Biopharmaceuticals Ltd.
Country	Israel
Country code	US
CUSIP number	98386D406
Earnings date	2026-06-30
Earnings time	amc
Employees	5
Employees change	-5
Employees growth	-50%
Enterprise value	$5.8M
Exchange	NASDAQ
Financial currency	USD
Financial report date	2025-12-31
First seen	2026-05-09
Fiscal year end	December
Founded	1993
Industry	Biotechnology
IPO date	2005-09-01
Is primary listing	No
Is SPAC	No
ISIN number	US98386D4060
Last 10-K release date	2026-06-30
Last earnings date	2026-06-30
Last refreshed	2026-11-04
Last stock split date	2026-03-25
Last stock split type	Reverse
Market cap	$5.9M
Market cap category	Nano-Cap
Next earnings date	2026-12-29
Options	No
Price	$1.73
Price currency	USD
Sector	Healthcare
SIC code	2834
Stock price date	2026-11-03
Symbol	XTLB
Website	https://www.xtlbio.com

Metric

Value

Amount currency

USD

CIK code

0001023549

Company name

XTL Biopharmaceuticals Ltd.

Country

Israel

Country code

CUSIP number

98386D406

Earnings date

2026-06-30

Earnings time

amc

Employees

Employees change

-5

Employees growth

-50%

Enterprise value

$5.8M

Exchange

NASDAQ

Financial currency

USD

Financial report date

2025-12-31

First seen

2026-05-09

Fiscal year end

December

Founded

1993

Industry

Biotechnology

IPO date

2005-09-01

Is primary listing

Is SPAC

ISIN number

US98386D4060

Last 10-K release date

2026-06-30

Last earnings date

2026-06-30

Last refreshed

2026-11-04

Last stock split date

2026-03-25

Last stock split type

Reverse

Market cap

$5.9M

Market cap category

Nano-Cap

Next earnings date

2026-12-29

Options

Price

$1.73

Price currency

USD

Sector

Healthcare

SIC code

2834

Stock price date

2026-11-03

Symbol

XTLB

Website

https://www.xtlbio.com

Metric	Value
Earnings yield	-183.18%
FCF / EV yield	-17.59%
FCF yield	-17.36%
Sector forward P/E	24x
Sector P/E	49.18x

Metric

Value

Earnings yield

-183.18%

FCF / EV yield

-17.59%

FCF yield

-17.36%

Sector forward P/E

24x

Sector P/E

49.18x

Metric	Value
Profit per employee	$-1.4M
ROA	-21.01%
ROA (5Y)	-12.86%
ROCE	576.77%
ROE	-29.3%
ROE (5Y)	-19.9%
ROIC	-34.43%

Metric

Value

Profit per employee

$-1.4M

ROA

-21.01%

ROA (5Y)

-12.86%

ROCE

576.77%

ROE

-29.3%

ROE (5Y)

-19.9%

ROIC

-34.43%

Metric	Value
EPS growth years	0
Net income growth years	0
Revenue growth years	0

Metric

Value

EPS growth years

Net income growth years

Revenue growth years

Metric	Value
Depreciation and amortization	$199,000
EBIT	$-1.5M
EBITDA	$-1.3M
EPS	$-3.16
FCF per share	$-0.00
Financing cash flow	$208,000
Free cash flow	$-1M
Free cash flow minus SBC	$-1.4M
Investing cash flow	$522,000
Net borrowing	$208,000
Net cash flow	$-295,000
Net income	$-7M
Operating cash flow minus SBC	$-1.4M
Operating income	$-1.5M
Stock-based compensation	$346,000

Metric

Value

Depreciation and amortization

$199,000

EBIT

$-1.5M

EBITDA

$-1.3M

EPS

$-3.16

FCF per share

$-0.00

Financing cash flow

$208,000

Free cash flow

$-1M

Free cash flow minus SBC

$-1.4M

Investing cash flow

$522,000

Net borrowing

$208,000

Net cash flow

$-295,000

Net income

$-7M

Operating cash flow minus SBC

$-1.4M

Operating income

$-1.5M

Stock-based compensation

$346,000

Metric	Value
Book value per share	$-0.00
Interest coverage	-209.29
Long-term assets	$0
Long-term liabilities	$0
Net cash (debt)	$76,000
Net cash / market cap	1.29%
Net cash growth	-92.44%
Piotroski F-Score	1
Shareholders' equity	$-254,000
Tangible book value	$-254,000
Tangible book value per share	$-0.00
Total assets	$166,000
Total cash	$76,000
Total debt	$0
Total liabilities	$420,000
WACC	6.59%

Metric

Value

Book value per share

$-0.00

Interest coverage

-209.29

Long-term assets

Long-term liabilities

Net cash (debt)

$76,000

Net cash / market cap

1.29%

Net cash growth

-92.44%

Piotroski F-Score

Shareholders' equity

$-254,000

Tangible book value

$-254,000

Tangible book value per share

$-0.00

Total assets

$166,000

Total cash

$76,000

Total debt

Total liabilities

$420,000

WACC

6.59%

Metric	Value
Current assets	$166,000
Current liabilities	$420,000
Current ratio	0.4
Net working capital	$-330,000
Quick ratio	0.18
Working capital	$-254,000

Metric

Value

Current assets

$166,000

Current liabilities

$420,000

Current ratio

0.4

Net working capital

$-330,000

Quick ratio

0.18

Working capital

$-254,000

Metric	Value
Buyback yield / dilution	-52.32%
Dividend yield	0%
Shareholder yield	-52.32%

Metric

Value

Buyback yield / dilution

-52.32%

Dividend yield

Shareholder yield

-52.32%

Metric	Value
10Y price change	-89.28%
10Y return CAGR	-20.01%
10Y total return	-89.28%
150-day SMA	$2.52
15Y price change	-96.68%
15Y return CAGR	-20.31%
15Y total return	-96.68%
1D price change	1.47%
1M price change	-20.14%
1M total return	-20.14%
1W price change	-4.7%
1W total return	-4.7%
1Y price change	-59.7%
1Y return CAGR	-59.72%
1Y total return	-59.7%
20-day SMA	$1.89
200-day SMA	$2.71
20Y price change	-99.73%
20Y return CAGR	-25.66%
20Y total return	-99.73%
3M price change	-38.83%
3M total return	-38.83%
3Y price change	-50.43%
3Y return CAGR	-20.85%
3Y total return	-50.43%
50-day SMA	$2.21
50-day SMA vs 200-day SMA	50under200
52-week high	$5.64
52-week high date	2026-01-13
52-week low	$1.60
52-week low date	2026-10-30
5Y price change	-88.91%
5Y return CAGR	-35.59%
5Y total return	-88.91%
6M price change	-52.74%
6M total return	-52.74%
After-hours change	3.77%
After-hours close	$1.73
After-hours price	$1.79
All-time high	$2,400.00
All-time high date	2005-09-01
All-time low	$1.60
All-time low date	2026-10-30
Average true range (ATR)	$0.16
Average volume	6.8K
Beta (5Y)	0.43
Change from 52-week high	-69.41%
Change from 52-week low	7.81%
Change from all-time high	-99.93%
Change from all-time low	7.81%
Change from open	-4.17%
Day's gap	5.88%
Dollar volume	$9,480
High price	$1.86
Low price	$1.66
Monthly RSI	37.73
Open price	$1.80
Position in 52-week range	32.5%
Premarket change	5.51%
Premarket close	$1.73
Premarket price	$1.82
Premarket volume	100
Previous close	$1.70
Price vs 150-day SMA	-31.57%
Price vs 20-day SMA	-8.73%
Price vs 200-day SMA	-36.25%
Price vs 50-day SMA	-21.91%
Relative volume	0.8
RSI	39.61
Sharpe ratio	-0.35
Sharpe ratio (3Y)	0.38
Sharpe ratio (5Y)	0.1
Sortino ratio	-0.59
Sortino ratio (3Y)	0.85
Sortino ratio (5Y)	0.25
Volume	5.5K
Weekly RSI	36.39
YTD price change	-25.65%
YTD total return	-25.65%

Metric

Value

10Y price change

-89.28%

10Y return CAGR

-20.01%

10Y total return

-89.28%

150-day SMA

$2.52

15Y price change

-96.68%

15Y return CAGR

-20.31%

15Y total return

-96.68%

1D price change

1.47%

1M price change

-20.14%

1M total return

-20.14%

1W price change

-4.7%

1W total return

-4.7%

1Y price change

-59.7%

1Y return CAGR

-59.72%

1Y total return

-59.7%

20-day SMA

$1.89

200-day SMA

$2.71

20Y price change

-99.73%

20Y return CAGR

-25.66%

20Y total return

-99.73%

3M price change

-38.83%

3M total return

-38.83%

3Y price change

-50.43%

3Y return CAGR

-20.85%

3Y total return

-50.43%

50-day SMA

$2.21

50-day SMA vs 200-day SMA

50under200

52-week high

$5.64

52-week high date

2026-01-13

52-week low

$1.60

52-week low date

2026-10-30

5Y price change

-88.91%

5Y return CAGR

-35.59%

5Y total return

-88.91%

6M price change

-52.74%

6M total return

-52.74%

After-hours change

3.77%

After-hours close

$1.73

After-hours price

$1.79

All-time high

$2,400.00

All-time high date

2005-09-01

All-time low

$1.60

All-time low date

2026-10-30

Average true range (ATR)

$0.16

Average volume

6.8K

Beta (5Y)

0.43

Change from 52-week high

-69.41%

Change from 52-week low

7.81%

Change from all-time high

-99.93%

Change from all-time low

7.81%

Change from open

-4.17%

Day's gap

5.88%

Dollar volume

$9,480

High price

$1.86

Low price

$1.66

Monthly RSI

37.73

Open price

$1.80

Position in 52-week range

32.5%

Premarket change

5.51%

Premarket close

$1.73

Premarket price

$1.82

Premarket volume

100

Previous close

$1.70

Price vs 150-day SMA

-31.57%

Price vs 20-day SMA

-8.73%

Price vs 200-day SMA

-36.25%

Price vs 50-day SMA

-21.91%

Relative volume

0.8

RSI

39.61

Sharpe ratio

-0.35

Sharpe ratio (3Y)

0.38

Sharpe ratio (5Y)

0.1

Sortino ratio

-0.59

Sortino ratio (3Y)

0.85

Sortino ratio (5Y)

0.25

Volume

5.5K

Weekly RSI

36.39

YTD price change

-25.65%

YTD total return

-25.65%

Metric	Value
Float	942.3M
Float percentage	95.86%
Shares change (YoY)	52.32%
Shares held by insiders	28.85%
Shares held by institutions	0.37%
Shares outstanding	983M
Short % of shares	0.23%
Short ratio	0.5 days

Metric

Value

Float

942.3M

Float percentage

95.86%

Shares change (YoY)

52.32%

Shares held by insiders

28.85%

Shares held by institutions

0.37%

Shares outstanding

983M

Short % of shares

0.23%

Short ratio

0.5 days

XTL Biopharmaceuticals Ltd. (XTLB)

Price

Financial snapshot

Fair-value bridge

Latest news · XTLB

Valuation

Profitability

Balance sheet

Trading

Next earnings

Sector percentile context

All XTLB indicators

Profile and market data

Valuation

Profitability

Growth

Financial statements

Financial strength

Liquidity

Dividends and buybacks

Performance and technicals

Ownership and float

Deeper analysis on XTLB

Frequently asked questions